1015 Capital Partners’s Pfizer PFE Stock Holding History

1015 Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.8K	Buy	1,196 +1	+0.1%	+$26	0.02%	165
2026 Q1	$33.6K	Hold	1,195	–	–	0.03%	162
2025 Q4	$29.8K	Buy	+1,195	New	+$30.1K	0.03%	166

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

1015 Capital Partners's PFE Position: Q2 2026 in Review

1015 Capital Partners increased its Pfizer (PFE) stake by 0.08% in Q2 2026, buying an estimated $26 and bringing the position to 1,196 shares worth $28.8K. The position accounts for 0.02% of the portfolio, ranked #165.

1015 Capital Partners first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $33.6K in Q1 2026. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

1015 Capital Partners held 1,196 shares of Pfizer worth $28.8K as of Q2 2026.
1015 Capital Partners bought 1 Pfizer share in Q2 2026, an estimated $26.
Pfizer made up 0.02% of 1015 Capital Partners's portfolio in Q2 2026, its #165 holding.
1015 Capital Partners first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
1015 Capital Partners's Pfizer position peaked at $33.6K in Q1 2026.
2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.